Interferon-based therapy for dialysis patients with chronic hepatitis C: Progress and challenges

被引：7
|
作者：
Liu, Chen-Hua [1 ]
Liu, Chun-Jen
Kao, Jia-Horng
机构：
[1] Natl Taiwan Univ, Coll Med, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Med Res, Taipei 10764, Taiwan
[3] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 10764, Taiwan
[4] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan
[5] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
NEPHROLOGY | 2007年 / 12卷 / 01期
关键词：
D O I：
10.1111/j.1440-1797.2006.00703.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8 / 10
页数：3
相关论文
共 50 条
  • [31] Experience with neuropsychiatric complications of interferon-based therapy for chronic viral hepatitis
    Mullen, KD
    ENCEPHALOPATHY AND NITROGEN METABOLISM IN LIVER FAILURE, 2003, : 153 - 157
  • [32] PREDICTORS OF SUSTAINED RESPONSE TO INTERFERON-BASED THERAPY IN CHRONIC HEPATITIS B
    Jelev, Deian
    Antonov, Krasimir
    Ivanova, Aneta
    Krastev, Zahariy
    JOURNAL OF IMAB, 2011, 17 (01): : 154 - 157
  • [33] Interferon-based treatment of chronic hepatitis D
    Sandmann, Lisa
    Wedemeyer, Heiner
    LIVER INTERNATIONAL, 2023, 43 : 69 - 79
  • [34] Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit
    Vafiadis, Irene
    Trilianos, Panagiotis
    Vlachogiannakos, Jiannis
    Karagiorga, Markisia
    Hatziliami, Antonia
    Voskaridou, Ersi
    Ladas, Spiros D.
    ANNALS OF HEPATOLOGY, 2013, 12 (04) : 364 - 370
  • [35] Direct-acting antivirals and interferon-based therapy on hepatocellular carcinoma risk in chronic hepatitis-C patients
    Ma, Longteng
    Liu, Jiluo
    Wang, Wei
    Yang, Fan
    Li, Ping
    Cai, Shiliang
    Zhou, Xinyu
    Chen, Xi
    Zhuang, Xun
    Zhang, Hongwei
    Cao, Guangwen
    FUTURE ONCOLOGY, 2020, 16 (11) : 675 - 686
  • [36] Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy
    El Din, Noha G. Bader
    Abd El Meguid, Mai
    Tabll, Ashraf A.
    Anany, Mohamed A.
    Esmat, Gamal
    Zayed, Naglaa
    Helmy, Amr
    El Zayady, Abdel Rahman
    Barakat, Ahmed
    El Awady, Mostafa K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (01) : 55 - 62
  • [37] Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan
    Hsu, C-S
    Kao, J-H
    Chao, Y-C
    Lin, H. H.
    Fan, Y-C
    Huang, C-J
    Tsai, P-S
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (04) : 415 - 423
  • [38] Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy
    Hung, Chao-Hung
    Lee, Chuan-Mo
    Wang, Jing-Houng
    Hu, Tsung-Hui
    Chen, Chien-Hung
    Lin, Chih-Yun
    Lu, Sheng-Nan
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (10) : 2344 - 2352
  • [39] Serum levels of tyrosine decrease with sustained virological response in patients with chronic hepatitis C treated by interferon-based therapy
    Shinohara, Mie
    Koji, Ishii
    Michio, Kogame
    Wakui, Noritaka
    Ikehara, Takashi
    Masao, Shinohara
    Nagai, Hidenari
    Watanabe, Manabu
    Igarashi, Yoshihiro
    Sumino, Yasukiyo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 203 - 204
  • [40] Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy
    Narita, Yutaka
    Genda, Takuya
    Tsuzura, Hironori
    Sato, Shunsuke
    Kanemitsu, Yoshio
    Ishikawa, Sachiko
    Kikuchi, Tetsu
    Hirano, Katsuharu
    Iijima, Katsuyori
    Wada, Ryo
    Ichida, Takafumi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 137 - 143
12345